MWNA
SRNE

Marshall Wace North America’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Marshall Wace North America’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-115,009
Closed -$230K – 1578
2017
Q2 		$230K Buy
+115,009
New +$230K ﹤0.01% 1204